RAC1 and pulmonary arterial hypertension: Exo-ITGB1 was found to suppress hypoxia-induced pulmonary vascular remodeling, proliferation and migration of PASMCs through Rac1 inhibition, suggesting Exo-ITGB1 enriched with miR-429-3p as a potential PAH therapy.